HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Dynavax Technologies (NASDAQ:DVAX) and maintained a $29 price target.
May 09, 2024 | 10:50 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dynavax Technologies maintains a Buy rating and a $29 price target from HC Wainwright & Co.
The reiteration of a Buy rating and maintenance of a $29 price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's future performance. This endorsement can positively influence investor sentiment and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100